Jinxiu Lin

Dr. Jinxiu Lin

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZWZhiyuan Weng
Zhiyuan Weng
XLXiaobo Li
Xiaobo Li
YLYuqiong Li
Yuqiong Li
JLJinxiu Lin
Jinxiu Lin
FPFeng Peng
Feng Peng
Wenquan NiuWenquan Niu
Wenquan Niu
Evidence is mounting suggesting that a strong genetic component underlies aspirin insensitivity. To generate more information, we aimed to evaluate the association of four common polymorphisms (rs3842787, rs20417, rs201184269, rs1126643) from four candidate genes (COX-1, COX-2, ITGA2B, ITGA2) with aspirin insensitivity via a meta-analysis. In total, there were 4 (353/595), 6 (344/698), 10 (588/878) and 7 (209/676) articles (patients/controls) qualified for rs3842787, rs20417, rs20118426 and rs1126643, respectively. The data were extracted in duplicate and analyzed by STATA software (Version 11.2). The risk estimate was expressed as odds ratio (OR) and 95% confidence interval (95% CI). Analyses of the full data set indicated significant associations of rs20417 (OR; 95% CI; P: 1.86; 1.44–2.41; <0.0005) and rs1126643 (2.37; 1.44–3.89; 0.001) with aspirin insensitivity under allelic model. In subgroup analyses, the risk estimate for rs1126643 was greatly potentiated among patients with aspirin semi-resistance relative to those with aspirin resistance, especially under dominant model (aspirin semi-resistance: 5.44; 1.42–20.83; 0.013 versus aspirin resistance: 1.96; 1.07–3.6; 0.03). Further grouping articles by ethnicity observed a stronger prediction of all, but rs20417, examined polymorphisms for aspirin insensitivity in Chinese than in Caucasians. Finally, meta-regression analyses observed that the differences in percentage of coronary artery disease (P = 0.034) and averaged platelet numbers (P = 0.012) between two groups explained a large part of heterogeneity for rs20417 and rs1126643, respectively. Our findings provide strong evidence that COX-2 and ITGA2 genetic defects might increase the risk of having aspirin insensitivity, especially for aspirin semi-resistance and in Chinese populations.

26 January 2017 in EBioMedicine
Verified
Journal Article
Open access
PDF file
FPFeng Peng
Feng Peng
DHDan Hu
Dan Hu
XLXiandong Lin
Xiandong Lin
GCGang Chen
Gang Chen
BLBinying Liang
Binying Liang
Wenquan NiuWenquan Niu
Wenquan Niu
Esophageal cancer is the fourth most common cancer in China, with a total of 477,900 new cases and 375,000 deaths projected to occur in 2015, and it is more common in males than in females ( Chen et al., 2016 x Chen et al., 2016 Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X.Q., and He, J. Cancer statistics in China, 2015. CA Cancer J. Clin. 2016; 66: 115–132 Crossref | PubMed | Scopus (5149) | Google Scholar See all References Chen et al., 2016 ). The two major histological types of esophageal cancer, viz. esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), which are distinct entities affected by diverse risk profiles, are now experiencing a global epidemiologic shift in recent decades ( Brown and Devesa, 2002 x Brown and Devesa, 2002 Brown, L.M. and Devesa, S.S. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg. Oncol. Clin. N. Am. 2002; 11: 235–256 Abstract | Full Text | Full Text PDF | PubMed | Scopus (367) | Google Scholar See all References , Alexandre et al., 2014 x Alexandre et al., 2014 Alexandre, L., Long, E., and Beales, I.L. Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J. Gastrointest. Pathophysiol. 2014; 5: 534–549 Crossref | PubMed | Google Scholar See all References , Rustgi and El-Serag, 2014 x Rustgi and El-Serag, 2014 Rustgi, A.K. and El-Serag, H.B. Esophageal carcinoma. N. Engl. J. Med. 2014; 371: 2499–2509 Crossref | PubMed | Scopus (364) | Google Scholar See all References ). Remarkably, compared with the most prevalent EAC in the U.S. and many Western countries, ESCC is the dominant histological type in China, and accounts for over 90% of esophageal cancer cases ( Torre et al., 2015 x Torre et al., 2015 Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., and Jemal, A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015; 65: 87–108 Crossref | PubMed | Scopus (13348) | Google Scholar See all References , Arnold et al., 2015 x Arnold et al., 2015 Arnold, M., Soerjomataram, I., Ferlay, J., and Forman, D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015; 64: 381–387 Crossref | PubMed | Scopus (304) | Google Scholar See all References ). Despite recent substantial advances in clinical diagnostic and therapeutic tools ( Sawayama et al., 2014 x Sawayama et al., 2014 Sawayama, H., Ishimoto, T., Watanabe, M., Yoshida, N., Sugihara, H., Kurashige, J., Hirashima, K., Iwatsuki, M., Baba, Y., Oki, E., Morita, M., Shiose, Y., and Baba, H. Small molecule agonists of PPAR-gamma exert therapeutic effects in esophageal cancer. Cancer Res. 2014; 74: 575–585 Crossref | PubMed | Scopus (24) | Google Scholar See all References , Messager et al., 2016 x Messager et al., 2016 Messager, M., Warlaumont, M., Renaud, F., Marin, H., Branche, J., Piessen, G., and Mariette, C. Recent improvements in the management of esophageal anastomotic leak after surgery for cancer. Eur J. Surg. Oncol. 2017; 43: 258–269 Abstract | Full Text | Full Text PDF | PubMed | Scopus (22) | Google Scholar See all References ), esophageal cancer exhibits an extremely poor prognosis with the 5-year survival rate of around 20% in China, mainly because it grows aggressively and is often diagnosed at an advanced stage ( Zeng et al., 2015 x Zeng et al., 2015 Zeng, H., Zheng, R., Guo, Y., Zhang, S., Zou, X., Wang, N., Zhang, L., Tang, J., Chen, J., Wei, K., Huang, S., Wang, J., Yu, L., Zhao, D., Song, G., Shen, Y., Yang, X., Gu, X., Jin, F., Li, Q., Li, Y., Ge, H., Zhu, F., Dong, J., Guo, G., Wu, M., Du, L., Sun, X., He, Y., Coleman, M.P., Baade, P., Chen, W., and Yu, X.Q. Cancer survival in China, 2003–2005: a population-based study. Int. J. Cancer. 2015; 136: 1921–1930 Crossref | PubMed | Scopus (239) | Google Scholar See all References , Tseng et al., 2015 x Tseng et al., 2015 Tseng, R.C., Chang, J.M., Chen, J.H., Huang, W.R., Tang, Y.A., Kuo, I.Y., Yan, J.J., Lai, W.W., and Wang, Y.C. Deregulation of SLIT2-mediated Cdc42 activity is associated with esophageal cancer metastasis and poor prognosis. J. Thorac. Oncol. 2015; 10: 189–198 Abstract | Full Text | Full Text PDF | PubMed | Scopus (15) | Google Scholar See all References , Klein and Stoecklein, 2009 x Klein and Stoecklein, 2009 Klein, C.A. and Stoecklein, N.H. Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma. Cancer Res. 2009; 69: 5285–5288 Crossref | PubMed | Scopus (39) | Google Scholar See all References ). One of the practical choices to improve overall survival is the identification of easy-to-obtain markers with prognostic significance for esophageal cancer by formulating more targeted and effective management strategies for high risk patients, such as metabolic profiling markers ( Yakoub et al., 2010 x Yakoub et al., 2010 Yakoub, D., Keun, H.C., Goldin, R., and Hanna, G.B. Metabolic profiling detects field effects in nondysplastic tissue from esophageal cancer patients. Cancer Res. 2010; 70: 9129–9136 Crossref | PubMed | Scopus (33) | Google Scholar See all References Yakoub et al., 2010 ).

25 August 2016 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
FPFeng Peng
Feng Peng
DHDan Hu
Dan Hu
XLXiandong Lin
Xiandong Lin
GCGang Chen
Gang Chen
BLBinying Liang
Binying Liang
Wenquan NiuWenquan Niu
Wenquan Niu
This prospective study sought to investigate the prediction of preoperative metabolic syndrome and its components for the risk of colorectal cancer (CRC) mortality by analyzing a subset of data from the ongoing Fujian prospective investigation of cancer (FIESTA) study. In total, 1,318 CRC patients who received radical resection were consecutively enrolled between January 2000 and December 2008. The median follow‐up time was 58.6 months, with 412 deaths from CRC. The CRC patients with metabolic syndrome had significantly shorter median survival time (MST) than those without (50.9 vs. 170.3 months, p < 0.001). Among four components of metabolic syndrome, hyperglycemia was the strongest predictor and its presence was associated with shorter MST than its absence (44.4 vs. 170.3 months, p < 0.001). Moreover, the complication of metabolic syndrome in CRC patients was associated with a 2.98‐fold increased risk of CRC mortality (hazard ratio [HR] = 2.98, 95% confidence interval [CI]: 2.40–3.69, p < 0.001) after adjusting for confounding factors. The magnitude of this association was especially potentiated in CRC patients with tumor‐node‐metastasis stage I/II (HR = 3.94, 95% CI: 2.65–5.85, p < 0.001), invasion depth T1/T2 (HR = 5.41, 95% CI: 2.54–11.50, p < 0.001), regional lymph node metastasis N0 (HR = 4.06, 95% CI: 2.85‐5.80, p < 0.001) and negative distant metastasis (HR = 3.23, 95% CI: 2.53–4.12, p < 0.001). Further survival tree analysis reinforced the prognostic capability of fasting blood glucose in CRC survival. Our findings convincingly demonstrated that preoperative metabolic syndrome, especially hyperglycemia, was a robust predictor for CRC mortality, and the protection was more obvious in patients with Stage I/II.

1 January 2017 in Journal of Cancer
Verified
Journal Article
Open access
FPFeng Peng
Feng Peng
DHDan Hu
Dan Hu
XLXiandong Lin
Xiandong Lin
GCGang Chen
Gang Chen
BLBinying Liang
Binying Liang
Wenquan NiuWenquan Niu
Wenquan Niu
Background and Aims: We sought to evaluate the prognosis of preoperative blood routine parameters for the mortality of colorectal cancer patients after surgery by eliciting a subset of data from the ongoing Fujian prospective investigation of cancer (FIESTA) study.

4 September 2013 in Gene
Verified
Journal Article
Closed access
FPFeng Peng
Feng Peng
DHDan Hu
Dan Hu
CGChaohao Gu
Chaohao Gu
XLXiaobo Li
Xiaobo Li
YLYuqiong Li
Yuqiong Li
Wenquan NiuWenquan Niu
Wenquan Niu

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
MZMeijin Zhang
Meijin Zhang
LLLiming Lin
Liming Lin
CXChangsheng Xu
Changsheng Xu
DCDajun Chai
Dajun Chai
FPFeng Peng
Feng Peng
JLJinxiu Lin
Jinxiu Lin
Background and aim. Upregulation of prolyl isomerase‐1 (Pin1) protein expression and activity was associated with the pathogenesis of diabetic vasculopathy through induction of endothelial oxidative stress and inflammation. Moreover, VDR agonist protects against high glucose‐induced endothelial apoptosis through the inhibition of oxidative stress. We aimed to explore the effects of the VDR agonist on diabetes‐associated endothelial dysfunction and the role of Pin1 in this process. Methods. Streptozocin‐induced diabetic mice were randomly treated with vehicle, VDR agonist (10 μg/kg/d, i.g., twice a week), or Pin1 inhibitor, Juglone (1 mg/kg/d, i.p., every other day), for eight weeks. In parallel, human umbilical vein endothelial cells (HUVECs) exposed to high‐glucose condition were treated with 1,25‐dihydroxyvitamin D3 and Juglone or vehicle for 72 hours. Organ chamber experiments were performed to assess endothelium‐dependent relaxation to acetylcholine. Circulatory levels of Pin1, SOD, MDA, IL‐1β, IL‐6, and NO in diabetic mice, Pin1 protein expression and activity, subcellular distribution of p66Shc, and NF‐κB p65 in high glucose‐cultured HUVECs were determined. Results. Both VDR agonist and Juglone significantly improved diabetes‐associated endothelial dysfunction and reduced high glucose‐induced endothelial apoptosis. Mechanistically, the circulatory levels of SOD and NO were increased compared with those of vehicle‐treated diabetic mice. Additionally, Pin1 protein expression and activity, p66Shc mitochondrial translocation, and NF‐κB p65 in high glucose‐cultured HUVECs were also inhibited by VDR agonist and Juglone. Knockdown of VDR abolished the inhibitory effects of VDR agonist on high glucose‐induced upregulation of Pin1 protein expression and activity. Conclusions. VDR agonist prevents diabetic endothelial dysfunction through inhibition of Pin1‐mediated mitochondrial oxidative stress and inflammation.